Hoje conversaremos com Thiago Cavalcanti Leal, Interno de Medicina da Universidade Federal de Alagoas sobre a nova epidemia de influenza com dúvidas comuns sobre o tema e esclarecimentos acerca da nova epidemia à luz das evidências científicas. 

Referências utilizadas para quem desejar se aprofundar sobre o tema: 

NORMAN, Daniel A. et al. Influenza hospitalizations in Australian children 2010–2019: The impact of medical comorbidities on outcomes, vaccine coverage, and effectiveness. Influenza and other respiratory viruses, 2021.

MONDIALE DE LA SANTÉ, Organisation et al. Weekly Epidemiological Record, 2021, vol. 96, 42 [full issue]. Weekly Epidemiological Record= Relevé épidémiologique hebdomadaire, v. 96, n. 42, p. 509-520, 2021.

Ravina, Manjeet, Mohan H, Narang J, Pundir S, Pundir CS. A changing trend in diagnostic methods of Influenza A (H3N2) virus in human: a review. 3 Biotech. 2021 Feb;11(2):87. doi: 10.1007/s13205-021-02642-w. Epub 2021 Jan 20. PMID: 33495723; PMCID: PMC7816835.

ejada S, Jansson M, Solé-Lleonart C, Rello J. Neuraminidase inhibitors are effective and safe in reducing influenza complications: meta-analysis of randomized controlled trials. Eur J Intern Med. 2021 Apr;86:54-65. doi: 10.1016/j.ejim.2020.12.010. Epub 2021 Jan 5. PMID: 33358065.

SIEGERS, Jurre Y. et al. Genetic and Antigenic Characterization of an Influenza A (H3N2) Outbreak in Cambodia and the Greater Mekong Subregion during the COVID-19 Pandemic, 2020. Journal of virology, v. 95, n. 24, p. e01267-21, 2021.